The contribution of CYP3a4 and CYP3A5 on the metabolism of sildenafil, vardenafil, and udenafil.

被引：0
|
作者：
Ku, H. [1 ]
Bae, S. [1 ]
Seo, K. [1 ]
Ahn, H. [1 ]
Bae, S. [1 ]
Shon, J. [1 ]
Liu, K. [1 ]
Shin, J. [1 ]
机构：
[1] Inje Univ, Coll Med, PharmacoGenom Res Ctr, Dept Pharmacol, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [1] Comparative drug metabolism by CYP3A4 and CYP3A5
    Huang, WL
    Lin, YS
    Dai, Y
    Totah, RA
    Calamia, JC
    Thummel, KE
    DRUG METABOLISM REVIEWS, 2003, 35 : 187 - 187
  • [2] USE OF THE CYP3A4 SELECTIVE INHIBITOR CYP3CIDE IN CYP3A5 GENOTYPED CRYOPRESERVED HUMAN HEPATOCYTES TO EXPLORE THE INDIVIDUAL CONTRIBUTION OF CYP3A4 AND CYP3A5 IN DRUG METABOLISM
    Heyward, Scott
    Schultz, Rachel N. V.
    Dennell, Stephen
    DRUG METABOLISM REVIEWS, 2014, 45 : 135 - 136
  • [3] The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism
    McGraw, Joseph
    Cherney, Mitchell
    Bichler, Katherine
    Gerhardt, Armin
    Nauman, Mirielle
    TOXICOLOGY LETTERS, 2019, 315 : 9 - 13
  • [4] The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
    Topletz, Ariel R.
    Dennison, Jennifer B.
    Barbuch, Robert J.
    Hadden, Chad E.
    Hall, Stephen D.
    Renbarger, Jamie L.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (09) : 1651 - 1661
  • [5] Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
    Lin, YS
    Dowling, ALS
    Quigley, SD
    Farin, FM
    Zhang, J
    Lamba, J
    Schuetz, EG
    Thummel, KE
    MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 162 - 172
  • [6] CYP3A4 and CYP3A5 genotyping by pyrosequencing
    Garsa, AA
    McLeod, HL
    Marsh, S
    BMC MEDICAL GENETICS, 2005, 6
  • [7] Comparison of CYP3A4 and CYP3A5 in Drug Metabolism and Drug Interactions
    Li, Shuanmei
    Liu, Duan
    Zhu, Juanli
    Cui, Yan
    Zhou, Ruimin
    Chen, Chao
    DRUG METABOLISM REVIEWS, 2009, 41 : 31 - 32
  • [8] The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype
    Shon, Ji-Hong
    Ku, Hei-Young
    Bae, Seol-Youn
    Oh, Min-Kyung
    Yeo, Chang-Woo
    Bae, Soo-Kyung
    Shin, Jae-Gook
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (12): : 820 - 828
  • [9] Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: Differential metabolism by CYP3A4 and CYP3A5
    Cook, CS
    Berry, LM
    Kim, DH
    Burton, EG
    Hribar, JD
    Zhang, LM
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) : 1344 - 1351
  • [10] Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans
    Santos, A
    Zanetta, S
    Cresteil, T
    Deroussent, A
    Pein, F
    Raymond, E
    Vernillet, L
    Risse, ML
    Boige, V
    Gouyette, A
    Vassal, G
    CLINICAL CANCER RESEARCH, 2000, 6 (05) : 2012 - 2020
12345